2-deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activation

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 86-90

  Haga, Naomi ^a   Naito, Mikihiko ^a   Seimiya, Hiroyuki ^b   Tomida, Akihiro ^a   Dong, Jian ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DEOXYGLUCOSE; ETOPOSIDE; MITOMYCIN C; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; DNA DAMAGE; DRUG ACTIVITY; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL NUCLEUS; DEOXYGLUCOSE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, MONOCYTIC, CHRONIC; MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031959734     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<86::AID-IJC14>3.0.CO;2-E     Document Type: Article

References (29)

1. CHEN, G.L., YANG, L., ROWE, T.C., HALLIGAN, B.D., TEWEY, K.M. and LIU, L.F., Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. biol. Chem., 259, 13560-13566 (1984).
2. EGUCHI, Y., SHIMIZU, S. and TSUJIMOTO, Y., Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res., 57, 1835-1840 (1997).
3. ENARI, M., TALANIAN, R.V., WONG, W.W. and NAGATA, S., Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380, 723-726 (1996).
4. ERHARDT, P. and COOPER, G.M., Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL. J. biol. Chem., 271, 17601-17604 (1996).
5. HALICKA, H.D., ARDELT, B., LI, X., MELAMED, M.M. and DARZYNKIEWICZ, Z., 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res., 55, 444-449 (1995).
6. ICHIJO, H., NISHIDA, E., IRIE, K., TEN DIJKE, P., SAITOH, M., MORIGUCHI, T., TAKAGI, M., MATSUMOTO, K., MIYAZONO, K. and GOTOH, Y., Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science, 275, 90-94 ( 1997).
7. JAMORA, C., DENNERT, G. and LEE, A.S., Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/ C10ME. Proc. nat. Acad. Sci. (Wash.), 93, 7690-7694 (1996).
8. KATAOKA, S., NAITO, M., TOMIDA, A. and TSURUO, T., Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells. Exp. Cell Res., 215, 199-205 (1994).
9. KAUFMANN, S.H., Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49, 5870-5878 (1989).
10. KERR, J.F., Shrinkage necrosis: a distinct mode of cellular death. J. Pathol., 105, 13-20 (1971).
11. KHARBANDA, S., REN, R., PANDEY, P., SHAFMAN, T.D., FELLER, S.M., WEICHSELBAUM, R.R. and KUFE, D.W., Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (Lond.), 376, 785-788 (1995).
12. KNOEPP, S.M., WISEHART-JOHNSON, A.E., BUSE, M.G., BRADSHAW, C.D., ELLA, K.M. and MEIER, K.E., Synergistic effects of insulin and phorbol ester on mitogen-activated protein kinase in Rat-1 HIR cells. J. biol. Chem., 271, 1678-1686 (1996).
13. MASHIMA, T., NAITO, M., FUJITA, N., NOGUCHI, K. and TSURUO, T., Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. biophys. Res. Comm., 217, 1185-1192 (1995a).
14. MASHIMA, T., NAITO, M., KATAOKA, S., KAWAI, H. and TSURUO, T., Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. biophys. Res. Comm., 209, 907-915 (19956).
15. MASHIMA, T., NAITO, M., NOGUCHI, K., MILLER, D.K., NICHOLSON, D.W. and TSURUO, T., Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene, 14, 1007-1012 (1997).
16. MUZIO, M. and 13 OTHERS, FLICE, a novel FADD-homologous ICE/CED-3-like protease. is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817-827 (1996).
17. NAITO, M., NAGASHIMA, K., MASHIMA, T. and TSURUO, T., Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. Blood, 89, 2060-2066 (1997).
18. O'CONNOR, P.M., KERRIGAN, D., BERTRAND, R., KOHN, K.W. and POMMIER, Y., 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells. Cancer Comm., 2, 395-400 (1990).
19. ROWE, T.C., CHEN, G.L., HSIANG, Y.H. and LIU, L.F., DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res., 46, 2021-2026 (1986).
20. SCHLEGEL, J., PETERS, I., ORRENIUS, S., MILLER, D.K., THORNBERRY, N.A., YAMIN, T.T. and NICHOLSON, D.W., CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J. biol. Chem., 271, 1841-1844 (1996).
21. SEIMIYA, H., MASHIMA, T., TOHO, M. and TSURUO, T., c-Jun NH2-terminal kinase-mediated activation of interleukin-1 beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. biol. Chem., 272, 4631-4636 (1997).
22. SU, B., JACINTO, E., HIBI, M., KALLUNKI, T., KARIN, M. and BEN-NERIAH, Y., JNK is involved in signal integration during costimulation of T lymphocytes. Cell, 77, 727-736 (1994).
23. TOMASZ, M., LIPMAN, R., CHOWDARY, D., PAWLAK, J., VERDINE, G.L. and NAKANISHI, K., Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science, 235, 1204-1208 (1987).
24. TOMIDA, A., SUZUKI, H., KIM, H.D. and TSURUO, T., Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene, 13, 2699-2705 (1996a).
25. TOMIDA, A., YUN, J. and TSURUO, T., Glucose-regulated stresses induce resistance to camptothecin in human cancer cells. Int. J. Cancer, 68, 391-396 (1996b).
26. VERHEIJ, M. and 12 OTHERS, Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (Lond.), 380, 75-79 (1996).
27. WYLLIE, A.M., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Land.), 284, 555-556 (1980).
28. XIA, Z., DICKENS, M., RAINGEAUD, J., DAVIS, R.J. and GREENBERG, M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331 (1995).
29. YUN, J., TOMIDA, A., NAGATA, K. and TSURUO, T., Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol Res., 7, 583-590 (1995).